First domestic approval of AI medical device to assist in diagnosing depression

News Healthcare & Pharma General Updates

Date: 23rd Dec, 2024 Source: Korea Food and Drug Administration (KFDA) Country: South Korea Original Source

Brief

"On "23/12/2024", the "Korea Food and Drug Administration (KFDA)" issued an update regarding " First domestic approval of AI medical device to assist in diagnosing depression". The approved software, ACRYL-D01, is a first-of-its-kind product that uses artificial intelligence to analyze patient interview records and display a depression probability score. This development aims to aid clinicians in early diagnosis and treatment of depression."

This content is restricted.

Highlights content goes here...

This content is restricted.

Korea Food and Drug Administration (KFDA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

First domestic approval of AI medical device to assist in diagnosing depression

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

First domestic approval of AI medical device to assist in diagnosing depression

Brief

Korea Food and Drug Administration (KFDA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.